Publications While At Healthpartners
Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial
Lancet (London, England).
Exenatide once weekly for the treatment of type 2 diabetes
Expert opinion on investigational drugs.
Map of science